中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Ziyou LIN)

1.Advances in treatment of immune-related adverse reactions and hyperprogressive diseases associated with antitumor immunotherapy with PD-1/PD-L1 monoclonal antibody drugs

Pengyan WANG ; Ziyou LIN ; Kai ZHU ; Xiaolei ZHANG

Chinese Journal of Pharmacology and Toxicology 2024;38(1):56-69

2.-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development.

Yi NIU ; Arabella WAN ; Ziyou LIN ; Xiongbin LU ; Guohui WAN

Acta Pharmaceutica Sinica B 2018;8(6):833-843

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO